Home
HEALTH CARE
Allergy and hay fever
Antineoplastic and immunomodulating agents
Circulatory system
Colds and flu
Dermatology
Digestive system
Eyes
For diabetics
Homeopathy
Musculoskeletal system
Non-sex hormones
Nutrikosmetics
Pain
Preparations for the treatment of infections
Sex and contraception
The immune system
The nervous system
Urogenital tract
Vitamins and minerals
HEALTHY LIFESTYLE
For athletes
Healthy food
Slimming
HYGIENE
Disinfection
Ear hygiene
Hot and cold compresses
Intimate hygiene
Laundry products
Oral hygiene
Slices and sticks
Urinary incontinence
COSMETICS
Cosmetic articles
For eyelashes and eyebrows
For face
For hair
For hands and nails
For the body
Soap
Sunbathing
To the feet
To the mouth
FOR HIM
Cosmetics for men
Health
PREGNANCY AND MOTHERHOOD
Accessories
Cosmetics for pregnant women
Health in pregnancy
Supporting fertility
CHILD
Baby nutrition
Child health
Cosmetics for children
Hygiene items for children
Oral hygiene (for children)
Scrolling
HEALTH CARE
Zolafren 10mg 30 tablets — Made in Poland by Adamed — Free Delivery
Zolafren 10mg 30 tablets — Made in Poland by Adamed — Free Delivery
Brand:
ADAMED
Product Code:
Zolafren 10mg
Availability:
In Stock
$40.36
Add to Cart
Description
Product description
Zolafren tablets are indicated for:
treatment of schizophrenia;
maintaining the achieved clinical effect with long-term therapy in patients who have observed a response to initial therapy;
treatment of moderate and severe manic episodes;
prevention of recurrent seizures in patients with bipolar disorder who have responded positively to olanzapine treatment for mania.
Compound
Active ingredient: 1 tablet contains 5 mg or 10 mg of olanzapine;
Excipients: lactose, microcrystalline cellulose, sodium starch (type A), magnesium stearate;
Shell: hypromellose (hypromellose), polyethylene glycol (Macrogol) 400, Yellow No.6 Al-Lake dye (E 110), titanium dioxide (E 171), iron oxide yellow (E172), lactose.
Contraindications
Hypersensitivity to the active substance or to the auxiliary components of the preparation.
Known risk of angle-closure glaucoma.
Mode of application
Treatment of schizophrenia, manic episodes and prevention of relapse in bipolar disorder. The daily dose to be determined based on clinical status in the range of 5 to 20 mg per day. An increase in the recommended initial dose should be carried out at intervals of at least 24 hours only after a clinical examination. Olanzapine should be used with or without food, as food does not affect the absorption of the preparation. With the abolition of the preparation, the end of therapy should be carried out gradually.
Application features
pregnant
Olanzapine should be used during pregnancy only when the expected results justify the potential risk to the fetus.
Children
Olanzapine is not recommended for the treatment of children and adolescents.
Drivers
With caution, dizziness and drowsiness are possible.
Overdose
Symptoms. Very common (> 10%): tachycardia, agitation/aggression, dysarthria, various extrapyramidal symptoms and decreased level of consciousness, ranging from sedation to coma.
Other significant complications of overdose are delirium, convulsions, coma, the possibility of neuroleptic malignant syndrome, respiratory depression, aspiration, arterial hypertension or hypotension, cardiac arrhythmias (<2% of overdose cases) and cardiopulmonary shock. Fatal outcomes have been reported with acute overdose at the 450 mg level, but there have been cases of survival after acute overdose after taking 2 g of olanzapine orally.
Treatment. There is no specific antidote. Preparations that cause vomiting are not recommended. Recommended standard procedures for overdose (for example, gastric lavage, activated charcoal). Co-administration of activated charcoal has been found to reduce oral bioavailability of olanzapine by 50-60%.
Side effects
The most common adverse reactions (observed in ≥ 1% of patients) associated with the use of olanzapine in clinical studies were: drowsiness, weight gain, eosinophilia, increased levels of prolactin, cholesterol (cholesterol), glucose and triglycerides in the blood, glycosuria, increased appetite, dizziness, akathisia, parkinsonism, leukopenia, neutropenia, dyskinesia, orthostatic hypotension, anticholinergic effects, transient asymptomatic increase in hepatic transaminases, rash, asthenia, fatigue, hyperthermia, arthralgia, elevated levels of alkaline phosphatase, gammaglutamyltransferase, uric acid, CPK, and edema .
Interaction
Caution should be exercised when olanzapine is administered with other preparations known to increase the QTc interval.
Storage conditions
Store at a temperature not exceeding 25°C, in the original packaging.
Keep out of the reach of children.
Shelf life - 3 years.
0 reviews
There are no reviews for this product.